173 related articles for article (PubMed ID: 38869039)
1. Plasma/Serum Proteomics based on Mass Spectrometry.
Zhu Y
Protein Pept Lett; 2024; 31(3):192-208. PubMed ID: 38869039
[TBL] [Abstract][Full Text] [Related]
2. Revisiting biomarker discovery by plasma proteomics.
Geyer PE; Holdt LM; Teupser D; Mann M
Mol Syst Biol; 2017 Sep; 13(9):942. PubMed ID: 28951502
[TBL] [Abstract][Full Text] [Related]
3. Early Cancer Biomarker Discovery Using DIA-MS Proteomic Analysis of EVs from Peripheral Blood.
Espejo C; Lyons B; Woods GM; Wilson R
Methods Mol Biol; 2023; 2628():127-152. PubMed ID: 36781783
[TBL] [Abstract][Full Text] [Related]
4. Rapid Isolation of Extracellular Vesicles from Blood Plasma with Size-Exclusion Chromatography Followed by Mass Spectrometry-Based Proteomic Profiling.
Kreimer S; Ivanov AR
Methods Mol Biol; 2017; 1660():295-302. PubMed ID: 28828666
[TBL] [Abstract][Full Text] [Related]
5. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
6. Clinical Proteomics for the Analysis of Circulating Extracellular Vesicles.
Barrachina MN; García Á
Methods Mol Biol; 2021; 2259():13-23. PubMed ID: 33687706
[TBL] [Abstract][Full Text] [Related]
7. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.
Shi T; Zhou JY; Gritsenko MA; Hossain M; Camp DG; Smith RD; Qian WJ
Methods; 2012 Feb; 56(2):246-53. PubMed ID: 21925605
[TBL] [Abstract][Full Text] [Related]
8. Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles.
Kverneland AH; Østergaard O; Emdal KB; Svane IM; Olsen JV
Proteomics; 2023 Apr; 23(7-8):e2200039. PubMed ID: 36398564
[TBL] [Abstract][Full Text] [Related]
9. Immune capture and protein profiling of small extracellular vesicles from human plasma.
Skoczylas Ł; Gawin M; Fochtman D; Widłak P; Whiteside TL; Pietrowska M
Proteomics; 2024 Jun; 24(11):e2300180. PubMed ID: 37713108
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-based plasma proteomics: state of the art and future outlook.
Pernemalm M; Lehtiö J
Expert Rev Proteomics; 2014 Aug; 11(4):431-48. PubMed ID: 24661227
[TBL] [Abstract][Full Text] [Related]
11. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.
Cohen Freue GV; Meredith A; Smith D; Bergman A; Sasaki M; Lam KK; Hollander Z; Opushneva N; Takhar M; Lin D; Wilson-McManus J; Balshaw R; Keown PA; Borchers CH; McManus B; Ng RT; McMaster WR;
PLoS Comput Biol; 2013 Apr; 9(4):e1002963. PubMed ID: 23592955
[TBL] [Abstract][Full Text] [Related]
12. A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas.
Farrah T; Deutsch EW; Omenn GS; Campbell DS; Sun Z; Bletz JA; Mallick P; Katz JE; Malmström J; Ossola R; Watts JD; Lin B; Zhang H; Moritz RL; Aebersold R
Mol Cell Proteomics; 2011 Sep; 10(9):M110.006353. PubMed ID: 21632744
[TBL] [Abstract][Full Text] [Related]
13. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
[TBL] [Abstract][Full Text] [Related]
15. Mixed-mode ion exchange-based integrated proteomics technology for fast and deep plasma proteome profiling.
Xue L; Lin L; Zhou W; Chen W; Tang J; Sun X; Huang P; Tian R
J Chromatogr A; 2018 Aug; 1564():76-84. PubMed ID: 29935814
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
17. Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies.
Geyer PE; Voytik E; Treit PV; Doll S; Kleinhempel A; Niu L; Müller JB; Buchholtz ML; Bader JM; Teupser D; Holdt LM; Mann M
EMBO Mol Med; 2019 Nov; 11(11):e10427. PubMed ID: 31566909
[TBL] [Abstract][Full Text] [Related]
18. Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
Harel M; Geiger T
Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905
[TBL] [Abstract][Full Text] [Related]
19. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry.
Keshishian H; Burgess MW; Specht H; Wallace L; Clauser KR; Gillette MA; Carr SA
Nat Protoc; 2017 Aug; 12(8):1683-1701. PubMed ID: 28749931
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers: mining the biofluid proteome.
Veenstra TD; Conrads TP; Hood BL; Avellino AM; Ellenbogen RG; Morrison RS
Mol Cell Proteomics; 2005 Apr; 4(4):409-18. PubMed ID: 15684407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
